Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fear conditioning and methylphenidate effects in antisocial adolescent males
NL-OMON39929Recruiting
- Sponsor
- Amsterdam UMC, location VUmc
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of methylphenidate in Disruptive behavior disorders (DBD), oppositional defiant disorder (ODD) and conduct disorder (CD) (2 arms), sponsored by Amsterdam UMC, location VUmc. Primary endpoint: Differential BOLD response during fear conditioning and reward/punishment sensitivity. Started Jul 2013; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
Disruptive behavior disorders (DBD)oppositional defiant disorder (ODD)conduct disorder (CD)
Beyond the preview
Go deeper on NL-OMON39929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39929.